Verrica Pharmaceuticals (VRCA) Current Assets (2017 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Current Assets of $34.1 million for Q1 2026, down 13.54% year-over-year from $39.5 million in Q1 2025, and down 19.77% quarter-over-quarter from $42.5 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Current Assets (2017 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Current Assets history runs 10 years deep, the most recent figure standing at $34.1 million for Q1 2026.
- In Q1 2026, Current Assets fell 13.54% year-over-year to $34.1 million; the TTM figure through Mar 2026 stood at $34.1 million (down 13.54% YoY), while the FY2025 annual figure was $42.5 million, down 16.88% from the prior year.
- Current Assets for Q1 2026 stood at $34.1 million, down from $42.5 million in the prior quarter.
- The five-year high for Current Assets was $91.7 million in Q3 2023, with the low at $28.2 million in Q3 2024.
- The 5-year median for Current Assets is $47.3 million (2024), against an average of $51.3 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets soared 111.37% in 2023, then sank 69.27% in 2024.
- Verrica Pharmaceuticals' Current Assets stood at $39.1 million in 2022, then surged by 98.21% to $77.5 million in 2023, then sank by 33.99% to $51.2 million in 2024, then dropped by 16.88% to $42.5 million in 2025, then fell by 19.77% to $34.1 million in 2026.
- Business Quant data shows VRCA's Current Assets at $34.1 million in Q1 2026, $42.5 million in Q4 2025, and $36.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Verrica Pharmaceuticals | 104.71 Mn | 93.51 Mn | - | 32.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.64 Mn |
| Mar 31, 2026 | 34.13 Mn |
| Dec 31, 2025 | 42.54 Mn |
| Sep 30, 2025 | 36.28 Mn |
| Jun 30, 2025 | 36.78 Mn |
| Mar 31, 2025 | 39.47 Mn |
| Dec 31, 2024 | 51.18 Mn |
| Sep 30, 2024 | 28.19 Mn |
| Jun 30, 2024 | 47.32 Mn |
| Mar 31, 2024 | 61.38 Mn |
| Dec 31, 2023 | 77.53 Mn |
| Sep 30, 2023 | 91.73 Mn |
| Jun 30, 2023 | 56.78 Mn |
| Mar 31, 2023 | 63.10 Mn |
| Dec 31, 2022 | 39.12 Mn |
| Sep 30, 2022 | 43.40 Mn |
| Jun 30, 2022 | 57.34 Mn |
| Mar 31, 2022 | 65.77 Mn |
| Dec 31, 2021 | 74.33 Mn |
| Sep 30, 2021 | 83.16 Mn |